| Ticker Symbol: | CALP |
|---|---|
| Exchange: | NASD |
| Contact Info: | 68 Elm Street Hopkinton MA 01748 508 435-9500 |
| CEO/President: | Kevin E. Hrusovsky |
| Industry: | Industrial Scientific / Standard Industry Code: 3826 |
| Description: | Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper\'s products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. |
| Shares Outstanding: | 48,390 (000) | Market Value: | 48,870 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 57.93% | Number of Inst.Shareholders: | 9.46% |
| Last Quarter Sales: | 34.04 ($Mil.) | Last Quarter Net Income: | -5.40 ($Mil.) |
| Last Quarter EPS: | -0.05 | P/E Ratio: | 0 |
| Most Recent Earnings: | 0.01 on 11/10/08 | Earnings Per Share: | -0.58 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| APPLERA CORP-AP | -18.00 | 29.29 | |
| PERKIN ELMER IN | -46.60 | 16.80 | |
| WATERS CP | -53.20 | 39.14 | |
| BRUKER CORPORAT | -58.70 | 4.61 | |
| MILLIPORE CP | -39.70 | 52.26 |
